← Open Payments lookup

JEFFREY WHEELER: Open Payments

NPI 1699942987 · ROOSEVELT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 28 payments from 10 companies in 2025. Trend: 2023 $323 · 2024 $408 · 2025 $541

Food & beverage: $541
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$160
Xeris Pharmaceuticals, Inc.5$105
ABBVIE INC.4$74
Corcept Therapeutics4$69
PFIZER INC.2$35
Janssen Biotech, Inc.2$32
Verona Pharma, Inc.1$26
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14
Axsome Therapeutics, Inc.1$9

Products named: AIRSUPRA, GVOKE HYPOPEN, Korlym, VRAYLAR, NURTEC ODT, TREMFYA, Ohtuvayre, FARXIGA.

Industry payments across UT — which companies pay providers there.